Balchem Corporation (BCPC) Market Cap & Valuation Ratios
Balchem Corporation (BCPC) has a market cap of $5.6B, a trailing P/E of 33.3 and a price-to-sales ratio of 5.1, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
BCPCBalchem CorporationFollow BCPC — free
—
Price chart with a free account
- Market cap
- 5.6B
- P/E TTM
- 33.3
- Dividend yield
- 0.5%
- 52-week
- —
- Next earnings
- 18 Feb, in 117 days
Peers
specialty chemicals · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| BCPC | 5.6 | 33.3 | 5.1 | 20.5 | 3.2% | +9% | 21% | 13% |
| WLK | 8.3 | — | 1.0 | — | -3.2% | -4% | -11% | -10% |
| ESI | 8.1 | 39.1 | 2.8 | 17.1 | 2.3% | +40% | 12% | 6% |
| NEU | 8.0 | 18.7 | 3.2 | 13.0 | 5.9% | -1% | 20% | 17% |
| EMN | 7.4 | 16.9 | 1.3 | 9.4 | 7.3% | -5% | 8% | 6% |
| AXTA | 7.3 | 21.1 | 1.9 | 9.9 | 6.8% | -0.9% | 13% | 9% |
| SXT | 5.6 | 35.8 | 3.7 | 21.2 | 0.1% | +8% | 14% | 9% |
| PRM | 4.6 | — | 7.5 | — | 2.1% | +24% | -51% | -20% |
| CLMT | 4.3 | — | 1.4 | 34.2 | 1.7% | +13% | 1% | 3% |
| CBT | 3.8 | 20.7 | 1.3 | 7.2 | 7.4% | -5% | 14% | 10% |
| AVNT | 3.8 | 22.2 | 1.6 | 10.3 | 5.1% | +2% | 9% | 6% |
| Median of these 10 | 21.1 | 1.7 | 11.6 | 3.7% | +0.7% | 11% | 6% |
P/E 33.3 vs. a peer median of 21.1; EV/Sales 5.1 vs. 1.7. BCPC's own P/E sits at the 3rd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesWLK and PRM and CLMT have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Balchem Corporation — questions
- What is Balchem Corporation's market cap?
- $5.6B.
- What is Balchem Corporation's P/E ratio?
- 33.3 on trailing twelve-month earnings to 2026-09-30.
- What is Balchem Corporation's price-to-sales ratio?
- 5.1.
Every figure on this page comes from Balchem Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.